Results 31 to 40 of about 13,974 (272)

Cost Implications of Left Atrial Appendage Occlusion During Cardiac Surgery: A Cost Analysis of the LAAOS III Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background The LAAOS III (Left Atrial Appendage Occlusion Study) clinical trial demonstrated that concomitant left atrial appendage (LAA) occlusion leads to a lower risk of ischemic stroke or systemic embolism compared with no occlusion in participants ...
Adam Eqbal, Wesley Tong, Andre Lamy, Emilie Belley‐Cote, Domenico Paparella, Alexander Bogachev‐Prokophiev, Alistair G. Royse, Wilko Reents, P. J. Devereaux, Katheryn Brady, Jessica Vincent, Stuart J. Connolly, Richard P. Whitlock   +12 more
doaj   +1 more source

Computational Fluid Dynamic Analysis of the Left Atrial Appendage to Predict Thrombosis Risk [PDF]

, 2018
During Atrial Fibrillation (AF) more than 90% of the left atrial thrombi responsible for thromboembolic events originate in the left atrial appendage (LAA), a complex small sac protruding from the left atrium (LA). Current available treatments to prevent
Andrew Cook, Gaetano Burriesci, Gaetano Burriesci, Giorgia Maria Bosi, Leon J. Menezes, Rajan Rai, Ryo Torii, Silvia Schievano   +7 more
core   +2 more sources

Acute Formation of Thrombus on a Left Atrial Appendage Occlusion Device Immediately After Detachment

JACC: Case Reports, 2023
Clots can form on the left atrial surface of left atrial appendage closure devices, with subsequent thromboembolization. However, we are unaware of any reports of clots forming on the devices immediately after deployment.
Ngoda Manongi, MD, MS, Alexander Volodarskiy, MD, Seth Goldbarg, MD   +2 more
doaj   +1 more source

Percutaneous left atrial appendage occlusion: putting the most lethal human attachment behind bars [PDF]

, 2012
Hospital Israelita Albert EinsteinUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de MedicinaCardiovascular Research FoundationUNIFESP ...
Caixeta, Adriano, Généreux, Philippe, Silva, Erlon O. De Abreu   +2 more
core   +3 more sources

Left Atrial Appendage Occlusion Debate Revisited [PDF]

Circulation, 2015
The left atrial appendage (LAA) has been deemed by some to be our “most lethal attachment,” and the concept of excluding it from systemic circulation has been thought to hold great promise. This concept has been around since 1948, when John Madden1 proclaimed it a plausible therapy for recurrent emboli in atrial fibrillation.
Richard P, Whitlock, Jeff S, Healey, David R, Holmes   +2 more
openaire   +2 more sources

Feasibility of Left Atrial Appendage Closure in Atrial Fibrillation Patients with a History of Intracranial Bleeding: A Systematic Review of Observational Studies

Journal of Interventional Cardiology, 2020
Background. Left atrial appendage occlusion (LAAO) is performed in patients with nonvalvular atrial fibrillation to reduce the risk of ischemic stroke.
Muhammad Ajmal, Qurat Ul Ain Riaz Sipra, Cristina Pecci, Nusrum Iqbal, Sulaiman Rathore   +4 more
doaj   +1 more source

Strategies to Incorporate Left Atrial Appendage Occlusion Into Clinical Practice [PDF]

, 2014
The left atrial appendage (LAA) has been identified as a predominant source of thrombus formation leading to significant thromboembolic events in patients with nonvalvular atrial fibrillation.
Alli, Oluseun, Asirvatham, Samuel, Holmes, David R.   +2 more
core   +1 more source

Left atrial appendage occlusion combined with cryoballoon or radiofrequency ablation: One-year follow-up comparison

Frontiers in Cardiovascular Medicine, 2023
BackgroundA one-stop procedure involving catheter ablation and left atrial appendage occlusion (LAAO) is an option for high-risk atrial fibrillation patients.
Yibo Ma, Lanyan Guo, Miaoyang Hu, Qun Yan, Haitao Liu, Fu Yi   +5 more
doaj   +1 more source

Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation [PDF]

, 2010
<p><b>Background and Purpose:</b> Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early ...
Awadh, M., Baird, T., MacDougall, N., Muir, K.W., Santosh, C., Teasdale, E.   +5 more
core   +1 more source

Case report: Vein of Marshall–catheter ablation combined with left atrial appendage occlusion for treatment of atrial fibrillation

Heliyon
The utilization of the one-stop strategy for treating atrial fibrillation (AF) has been on the rise, but the combination of vein of Marshall catheter ablation with left atrial appendage occlusion has been rarely reported.
Ning Zhu, Cong Lin, Yizhou Zhang, Wei Lin   +3 more
doaj   +1 more source